Accession PRJCA016234
Title To evaluate the safety and tolerability of anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors
Relevance Medical
Data types clinical,image,Metabolic data
Organisms Homo sapiens
Description To evaluate the safety and tolerability of anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors
Sample scope Multiisolate
Release date 2023-04-13
Grants
Agency program Grant ID Grant title
NA NA
Submitter wanqiu liang (wanqiu.liang@hengrui.com)
Organization Jiangsu Hengrui Pharmaceutical Co. LTD
Submission date 2023-04-13

Project Data

Resource name Description